Company / Return on Assets (ROA)
Centessa Pharmaceuticals plc Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-28.7%
FY2025
5-year range
-60.5% / -28.7%
FY2021-FY2025
Trend
+29.7%
vs FY2024
Sector context
#127 of 213
Health Care
What the data says
At -28.7%, Centessa Pharmaceuticals plc's return on assets (roa) ranks #127 of 213 in the Health Care sector. Return on Assets (ROA) has increased for 5 consecutive years, from -91.0% in FY2020 to -28.7% in FY2025.
Based on SEC 10-K filings.
-28.7% in FY2025 with a 5-year CAGR of +62.3%.
Improved from -41.9% to -28.7% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +19.9pp
- 5-Year Change
- +62.3pp
- 10-Year Change
- -
Sector benchmark
#127 of 213 in Health CareTop 60% of 213This company -28.7% Sector average -24.1%
▼
-19.0% below sector average
Key checks
Key Insights
- Centessa Pharmaceuticals plc's return on assets (roa) has grown for 5 consecutive years.
- In FY2025, return on assets (roa) increased 29.7% year-over-year.
- Currently 4.6pp below the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -28.7% | +29.7% |
| FY2024 | -40.9% | +2.6% |
| FY2023 | -41.9% | +13.8% |
| FY2022 | -48.7% | +19.6% |
| FY2021 | -60.5% | +33.5% |
| FY2020 | -91.0% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026